TVARDI THERAPEUTICS INC (TVRD) Stock Income Statement
NASDAQ:TVRD - Nasdaq - US1407553072 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.57M | 7.14M | 20.97M | 41.90M | 23.00M | |||
| Cost Of Goods | N/A | 620.00K | 6.17M | 7.30M | N/A | |||
| Gross Profit | N/A | 6.52M | 14.79M | 34.60M | N/A | |||
| Operating Expenses | 35.72M | 59.34M | 136.29M | 122.10M | 112.10M | |||
| Research and Development | 11.12M | 32.76M | 108.38M | 91.80M | 82.60M | |||
| Selling, General, and Administrative Expenses | 24.24M | 26.39M | 27.65M | 30.10M | 29.30M | |||
| Operating Income | -28.14M | -52.82M | -121.50M | -87.50M | -89.10M | |||
| Interest Income/Expense | 2.22M | 2.83M | 3.59M | 2.10M | 600.00K | |||
| Other Income/Expense | -9.36M | -8.47M | -604.00K | N/A | N/A | |||
| Non Recurring Items | -10.40M | -12.80M | N/A | N/A | N/A | |||
| Income Before Taxes | -45.46M | -71.27M | -118.51M | -85.50M | -88.40M | |||
| Income Tax | N/A | -398.00K | N/A | 0.00 | 0.00 | |||
| Net Income | -45.06M | -70.87M | -118.51M | -85.50M | -88.40M | |||
| EBITDA | N/A | -52.63M | -121.24M | -87.25M | -88.85M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -29.60 | -46.60 | -78.80 | -1.59 | -1.74 | |||
| Non GAAP EPS | N/A | N/A | -2.18 | -1.59 | -1.73 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 91.31% | 70.56% | 82.58% | N/A | |||
| Profit Margin | -595.18% | -992.95% | -565.21% | -204.06% | -384.35% | |||
| Operating Profit Margin | -371.73% | -740.06% | -579.43% | -208.83% | -387.39% | |||
All data in USD